Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Res Pract Thromb Haemost ; 4(5): 813-822, 2020 Jul.
Article in English | MEDLINE | ID: mdl-33134771

ABSTRACT

BACKGROUND: Correct diagnosis of the cause of thrombocytopenia is crucial for the appropriate management of patients. Hyposialylation/desialylation (characterized by abnormally high ß-galactose exposure) accelerates platelet clearance and can lead to thrombocytopenia. However, the reference range for ß-galactose exposure in healthy individuals has not been defined previously. OBJECTIVE: The objective of the present study was to develop a standardized assay of platelet ß-galactose exposure for implementation in a clinical laboratory. METHODS: ß-Galactose exposure was measured in platelet-rich plasma by using flow cytometry and Ricinus communis agglutinin (RCA). A population of 120 healthy adults was recruited to study variability. RESULTS: We determined an optimal RCA concentration of 12.5 µg/mL. The measure was stable for up to 4 hours (mean fluorescence intensity [MFI]-RCA: 1233 ± 329 at 0 hour and 1480 ± 410 at 4 hours). The platelet count did not induce a variation of RCA and the measure of RCA was stable when tested up to 24 hours after blood collection (MFI-RCA: 1252 ± 434 at day 0 and 1140 ± 297 24 hours after blood sampling). To take into account the platelet size, results should be expressed as RCA/forward scatter ratio. We used the assay to study variability in 120 healthy adults, and we found that the ratio is independent of sex and blood group. CONCLUSION: We defined a normal range in a healthy population and several preanalytical and analytical variables were evaluated, together with positive and negative controls. This assay may assist in the diagnosis of thrombocytopenic diseases linked to changes in ß-galactose exposure.

SELECTION OF CITATIONS
SEARCH DETAIL
...